AU2001258234A1 - Methods of modulating functions of polypeptide galnac-transferases and of screening substances therefor, pharmaceutical compositions comprising such agents - Google Patents

Methods of modulating functions of polypeptide galnac-transferases and of screening substances therefor, pharmaceutical compositions comprising such agents

Info

Publication number
AU2001258234A1
AU2001258234A1 AU2001258234A AU5823401A AU2001258234A1 AU 2001258234 A1 AU2001258234 A1 AU 2001258234A1 AU 2001258234 A AU2001258234 A AU 2001258234A AU 5823401 A AU5823401 A AU 5823401A AU 2001258234 A1 AU2001258234 A1 AU 2001258234A1
Authority
AU
Australia
Prior art keywords
galnac
transferases
polypeptide
transferase
polypeptide galnac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258234A
Other languages
English (en)
Inventor
Eric Paul Bennett
Henrik Clausen
Helle Hassan
Celso Albuquerque Reis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlycoZym ApS
Original Assignee
GlycoZym ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlycoZym ApS filed Critical GlycoZym ApS
Publication of AU2001258234A1 publication Critical patent/AU2001258234A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91091—Glycosyltransferases (2.4)
    • G01N2333/91097—Hexosyltransferases (general) (2.4.1)
    • G01N2333/91102—Hexosyltransferases (general) (2.4.1) with definite EC number (2.4.1.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001258234A 2000-05-11 2001-05-10 Methods of modulating functions of polypeptide galnac-transferases and of screening substances therefor, pharmaceutical compositions comprising such agents Abandoned AU2001258234A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20333100P 2000-05-11 2000-05-11
US60203331 2000-05-11
PCT/DK2001/000328 WO2001085215A2 (en) 2000-05-11 2001-05-10 METHODS OF MODULATING FUNCTIONS OF POLYPEPTIDE GalNAc TRANSFERASES AND OF SCREENING SUBSTANCES THEREFOR, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH AGENTS

Publications (1)

Publication Number Publication Date
AU2001258234A1 true AU2001258234A1 (en) 2001-11-20

Family

ID=22753535

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258234A Abandoned AU2001258234A1 (en) 2000-05-11 2001-05-10 Methods of modulating functions of polypeptide galnac-transferases and of screening substances therefor, pharmaceutical compositions comprising such agents

Country Status (5)

Country Link
EP (1) EP1282725B1 (de)
AT (1) ATE361375T1 (de)
AU (1) AU2001258234A1 (de)
DE (1) DE60128218D1 (de)
WO (1) WO2001085215A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338932B2 (en) 2000-05-11 2008-03-04 Glycozym Aps Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
DE60314658D1 (de) * 2002-11-08 2007-08-09 Glycozym Aps Verfahren zur identifizierung von die funktionen von polypeptid-galnac-transferasen modulierenden agentien, solche agentien umfassende pharmazeutische zusammensetzungen und verwendung solcher agentien zur herstellung von arzneimitteln
US20090142272A1 (en) * 2004-06-21 2009-06-04 Exelixis, Inc. Pfks as modifiers of the igfr pathway and methods of use
CA2977261A1 (en) 2006-10-04 2008-04-10 Kobenhavns Universitet Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies
US20120214174A1 (en) * 2009-08-25 2012-08-23 Oncotherapy Science, Inc. Gene and polypeptide relating to breast cancer
WO2014024820A1 (ja) * 2012-08-06 2014-02-13 塩野義製薬株式会社 新規慢性腎臓病治療用医薬組成物及び新規慢性腎臓病治療薬のスクリーニング方法
GB201406767D0 (en) 2014-04-15 2014-05-28 Cancer Rec Tech Ltd Humanized anti-Tn-MUC1 antibodies anf their conjugates
US11058675B2 (en) 2018-03-29 2021-07-13 Carnegie Mellon University Cell-based screening and compounds that modulate GaINAc-transferases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268364A (en) * 1991-12-12 1993-12-07 The Biomembrane Institute Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification
PL339773A1 (en) * 1997-09-05 2001-01-02 Glycim Oy Synthetic bivalent polylactose amines containing slex and method of using them
JP2002517474A (ja) * 1998-06-10 2002-06-18 グリコデザイン インコーポレイテッド 定方向のコンビナトリアル化合物ライブラリおよびそれをスクリーニングするための高スループットアッセイ

Also Published As

Publication number Publication date
DE60128218D1 (de) 2007-06-14
ATE361375T1 (de) 2007-05-15
EP1282725B1 (de) 2007-05-02
EP1282725A2 (de) 2003-02-12
WO2001085215A9 (en) 2002-01-24
WO2001085215A3 (en) 2002-06-27
WO2001085215A2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
US7338932B2 (en) Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
EP1558728B1 (de) Verfahren zur identifizierung von die funktionen von polypeptid-galnac-transferasen modulierenden agentien, solche agentien umfassende pharmazeutische zusammensetzungen und verwendung solcher agentien zur herstellung von arzneimitteln
Cummings Stuck on sugars–how carbohydrates regulate cell adhesion, recognition, and signaling
Song Roles of the nucleotide sugar transporters (SLC35 family) in health and disease
Spiro Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds
Hassan et al. The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptideN-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities
Hang et al. The chemistry and biology of mucin-type O-linked glycosylation
Kranz et al. A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If)
Choi et al. Engineering orthogonal polypeptide GalNAc-transferase and UDP-sugar pairs
Katrine et al. Site-specific protein O-glycosylation modulates proprotein processing—deciphering specific functions of the large polypeptide GalNAc-transferase gene family
US6569998B2 (en) Synthetic glycosulfopeptides and methods of synthesis thereof
JP2000507095A (ja) ネズミα（１，３）フコシルトランスフェラーゼＦｕｃ―ＴＶＩＩ、それをコードするＤＮＡ、その製造法、それを認識する抗体、それを検出するためのイムノアッセイ、このようなＤＮＡを含むプラスミド、およびこのようなプラスミドを含む細胞
Freire et al. Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase activity
US7078206B2 (en) UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GalNAc) β1,6N-acetylglucosaminyltransferase, C2GnT3
Yazawa et al. Aberrant α1→ 2fucosyltransferases found in human colorectal carcinoma involved in the accumulation of Leb and Y antigens in colorectal tumors
CN101273142A (zh) 用于癌症治疗的调节smyd3转移酶的化合物的鉴定
Bagdonaite et al. Mucin-type O-GalNAc glycosylation in health and disease
EP1282725B1 (de) METHODEN ZUR MODELIERUNG DIE FUNKTION VON POLYPEPTID GalNAc TRANSFERASEN UND ZURSCREENING SUBSTANZEN DAFÜR
Müller et al. Signalling via caveolin: involvement in the cross-talk between phosphoinositolglycans and insulin
Beum et al. Mucin biosynthesis: epidermal growth factor downregulates core 2 enzymes in a human airway adenocarcinoma cell line
JP2004517030A (ja) グリコシルトランスフェラーゼインヒビター
US20060063736A1 (en) Compositions and methods for inhibiting mucin-type O-linked glycosylation
US20030153056A1 (en) Glycosyltransferase proteins
Ram et al. Phosphorylation and dephosphorylation of calsequestrin on CK2-sensitive sites in heart
West et al. Glycosyltransferase genomics in Dictyostelium discoideum

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application